ライフサイエンスコーパス: blood collection

1 ncer cases were randomly sampled by month of blood collection.

2 identifying cases diagnosed within 1 year of blood collection.

3 a diagnosis of prostate cancer 5 years after blood collection.

4 controls by year of birth, race, and time of blood collection.

5 fasting status, and time of day and month of blood collection.

6 e, education, income, and gestational age at blood collection.

7 ls by age, sex, race/ethnicity, and dates of blood collection.

8 enzymatic breakdown generated after patient blood collection.

9 es diagnosed within approximately 4 years of blood collection.

10 fasting status, and time of day and month of blood collection.

11 ts is affected by the anticoagulant used for blood collection.

12 quately characterized in the month preceding blood collection.

13 ble if the plasma is separated within 6 h of blood collection.

14 clinical evidence of disease at the time of blood collection.

15 lection to assess discomfort associated with blood collection.

16 ryngeal SARS-CoV-2 RT-PCR within 24 hours of blood collection.

17 were asymptomatic during the month prior to blood collection.

18 or 14 days with longitudinal rectal swab and blood collection.

19 ases were diagnosed on average 8 years after blood collection.

20 or retrospectively by survey at the time of blood collection.

21 ed to complete a screening colonoscopy after blood collection.

22 interviews, anthropometric measurements, and blood collection.

23 ported VOCs triggered at-home or in-hospital blood collection.

24 fers advantages but faces limitations due to blood collection.

25 te-based and mobile phlebotomy were used for blood collection.

26 accines but did not have COVID-19 before the blood collection.

27 crease the number of future cases with cfDNA blood collection.

28 ssociated with live virus methods and venous blood collection.

29 dergo body measurements, an interview, and a blood collection.

30 sease activity were evaluated at the time of blood collection.

31 sting, exhaled nitric oxide measurement, and blood collection.

32 glycemic control in the months leading up to blood collection.

33 gs were obtained within three hours of whole blood collection.

34 en who were generally healthy at the time of blood collection.

35 enter, age, sex, fasting status, and time of blood collection.

36 $1/sample and analysis time was 30 min after blood collection.

37 cing the risk due to exposure to needles and blood collection.

38 race, ethnicity, cancer status, and date of blood collection.

39 es were generally completed within 9 days of blood collection.

40 ction to cases diagnosed 8 to 13 years after blood collection.

41 hed on age, year of birth, race, and time of blood collection.

42 The mean age was 58.7 y at blood collection.

43 iagnosed approximately 8 years or more after blood collection.

44 onnaire administered every 4 years, prior to blood collection.

45 , and time of day and duration of fasting at blood collection.

46 to cases on age at randomization and date of blood collection.

47 eported adverse events or complications from blood collections.

48 (1989 to 1990) and the second (2000 to 2002) blood collections; 10-year changes (Delta) in TMAO were

49 m 3 European birth cohorts (offspring age at blood collection: 16, 17, and 31 years).

50 rol was matched to each case on age, date of blood collection (1974-2006), sex, and race/ethnicity (n

51 gnosed cardiovascular disease at the time of blood collection, 266 had nonfatal myocardial infarction

52 sed on age, sex, fasting status, and time of blood collection, after adjusting for inflammation statu

53 and organ transplantation was recognized and blood collection agencies implemented West Nile virus nu

54 Periodic blood collection allows for evaluation of intervention-r

55 1 patients with NHL diagnosed 5+ years after blood collection and 301 control patients within the Pro

56 We recommend increased blood collection and adherence to strict transfusion tri

57 xyvitamin D after standardizing for month of blood collection and adjusting for covariates.

58 ing dried blood microsamples, could simplify blood collection and allow the setup of epidemiological

59 Median time between blood collection and ALS death was 8 years (range = 1-15

60 postmenopausal breast cancer diagnosed after blood collection and before June 2000, in which there we

61 Invasive methods such as blood collection and biopsy are commonly used for testin

62 nd vein were catheterized for drug infusion, blood collection and blood pressure measurements, and le

63 Blood collection and clinical testing preseason (uninjur

64 participants was independent of time between blood collection and diagnosis and was observed more tha

65 d to stage or grade of disease, time between blood collection and diagnosis, age and year of diagnosi

66 We compared how different methods of blood collection and handling affect isolation of this p

67 Between the first blood collection and June 2010, 2188 breast cancer cases

68 The average time between blood collection and MS onset was 4 years.

69 and drug effect was characterized both from blood collection and neuropsychological assessments.

70 We also determined the influence of blood collection and NGS preparations on the miRNA patte

71 gnostic study of blood samples from national blood collection and prion disease centers in the United

72 rease automation and extend the time between blood collection and processing for the T-SPOT.TB test f

73 The previous maximum time between blood collection and processing for the T-SPOT.TB test i

74 solation method allowed for the time between blood collection and processing to range from 0 to 55 h.

75 y extends the amount of time allowed between blood collection and processing up to 32 h.

76 e use, body mass index, and the time between blood collection and RA onset, we found that the daily a

77 age, case patients were 61.5 years of age at blood collection and received a diagnosis of prostate ca

78 Patients visited the clinic for predose blood collection and safety evaluation at baseline (days

79 dent cases in the WHS, the mean time between blood collection and the onset of RA symptoms was 5.2 ye

80 y for applications in the field where venous blood collection and timely shipment of labile blood sam

81 The results of the association between "blood collection" and "duration of injury" revealed a st

82 ated with age, state of residence, season of blood collection, and body mass index but not with tumor

83 controls matched by center, gender, date of blood collection, and date of birth.

84 by age, sex, study center, date and time of blood collection, and fasting status.

85 at baseline, study center, date and time of blood collection, and fasting status.

86 o controls for age, sex, race and ethnicity, blood collection, and military branch.

87 ted for matching factors, gestational age at blood collection, and prepregnancy body mass index.

88 atio and matched with regard to age, date of blood collection, and smoking status.

89 lly-invasive, low cost alternative to venous blood collection, and this scalable immunoassay-based me

90 onal Care Center were enrolled and underwent blood collection, and urine sampling before and after di

91 of caregiver swabs, 99% (92/93) of baseline blood collections, and 67% (9245/13 768) of scheduled sy

92 ere observed conducting venous and capillary blood collections, and pre- and posttests were offered d

93 Galacomannans were also found in blood collection anticoagulant and platelet additive sol

94 sex, storage time, library size, the unit of blood collection as well as age impose a certain degree

95 nd April 2016 underwent echocardiography and blood collection at baseline, after receiving anthracycl

96 4.8 g fat), or whole (7.9 g fat) milk before blood collection at regular intervals for 72 h.

97 d investigational practices surrounding cord blood collection, banking, and use.

98 significantly associated with younger age at blood collection, being premenopausal, having an older a

99 blanket a thumb lancet, and an object held a blood collection bowl, supported the hypothesis that it

100 ardial infarction (fatal and nonfatal) after blood collection but before July 1998.

101 e can conclude that athletes who do not have blood collection, but only interstitial haemorrhage betw

102 eminders, more intensive reminders increased blood collection by a mean of 0.11 units per year (95% C

103 ek shorter inter-donation interval increased blood collection by a mean of 0.23 units per year (0.21-

104 e and inaccessible due to the need for whole-blood collection by highly trained phlebotomists using p

105 Disruption of blood collection by political unrest, natural disasters

106 testing is limited by the need for in-person blood collection by staff trained in venepuncture, and t

107 g on probing (BOP) were collected on special blood collection cards and analyzed for HbA1c levels in

108 The valuable role that blood collection centers can play in increasing the samp

109 involve laboratory-based tests, followed by blood collection, conducted in a clinical setting as the

110 ctDNA was undetectable in the post-surgical blood collection, consistent with their lack of detectab

111 sex, birth date (within 1 year), center, and blood collection date (within 15 days).

112 93-2005) and 428 controls matched on age and blood collection date within the Alpha-Tocopherol, Beta-

113 hed on sex, cohort, age, race/ethnicity, and blood collection date.

114 hed on sex, cohort, age, race/ethnicity, and blood collection date.

115 ched on race, sex, age, enrollment site, and blood collection date.

116 included age, latitude, race/ethnicity, and blood collection date.

117 strated that using an ultrathin-wall cannula blood collection device can significantly increase blood

118 Our approach to using pDBS cards as a blood collection device has the potential to support at-

119 ization of cellular RNA, using the Tasso-SST blood collection device with a specially designed stabil

120 A blood-collection drape can help provide objective, accur

121 A calibrated blood-collection drape can help provide objective, accur

122 The intervention included a calibrated blood-collection drape for early detection of postpartum

123 VE intervention, which included a calibrated blood-collection drape for early detection of PPH and a

124 indings suggest that the use of a calibrated blood-collection drape for early detection of PPH and bu

125 artum haemorrhage detection using calibrated blood-collection drapes, followed by a postpartum haemor

126 We conducted 24-h serial blood collections during the baseline and intervention t

127 Participants underwent medical examination, blood collection, ECG, and echocardiogram at enrollment

128 Blood collection facilities rapidly implemented programs

129 and 1 severe) were reported to the regional blood collection facility.

130 from NHS II) matched for age, race, time of blood collection, fasting status, and (for NHS II) menop

131 During the 12 mo before blood collection, food intakes were assessed repeatedly

132 vity diary; and 4) clinical measurements and blood collection for 25(OH)D determination.

133 llected from patients at the time of routine blood collection for CAP/CTM demonstrated an overall agr

134 These measurements and blood collection for clinical biochemical markers were p

135 ded (1) automated EHR screening, (2) remnant blood collection for creation of a virtually enabled bio

136 exposed infants who had a documented date of blood collection for EID within Ministry of Health regis

137 pregnant women were offered HBV testing and blood collection for further retrospective HBV MTCT risk

138 ampling for drug quantification and a single blood collection for genomic evaluation.

139 Blood collection for laboratory testing in intensive car

140 luded echocardiogram, electrocardiogram, and blood collection for laboratory tests and mavacamten pla

141 tory years (LOY) as age at menopause (age at blood collection for premenopausal women) minus age at m

142 We estimated LOY as age at menopause (age at blood collection for premenopausal women) minus age at m

143 C) to baked egg (BE), skin prick testing and blood collection for serology and basophil activation te

144 tric assessments were conducted, followed by blood collection for the quantification of seven serum P

145 Study visits for safety and serial blood collections for antibody titres were done on enrol

146 vioral assessments, glucose tolerance tests, blood collections for oxidative stress markers, and ovar

147 did not significantly differ between type of blood collection (for example, 62% had high cholesterol

148 d due to several drawbacks related to venous blood collection, for example, cold chain transport.

149 IGF axis, and iron store plus age and BMI at blood collection from an existing case-control study nes

150 e studied using a shed blood model involving blood collection from skin incisions made using standard

151 ING, AND PARTICIPANTS: Ocular testing of and blood collections from a female astronaut were completed

152 those who initiated aspirin/NSAID use after blood collection had significant reductions in subsequen

153 Prior to blood collection in 1993-1994, physical activity and tel

154 iency are still lacking due to the difficult blood collection in remote regions.

155 to filter paper have eased the difficulty of blood collection in resource-limited settings.

156 is circumvents the need for venipuncture and blood collection in specialized vials by a phlebotomist

157 20s and the development of plastic packs for blood collection in the 1960s laid the groundwork for pl

158 ong subjects diagnosed closer to the date of blood collection in the two cohorts with sufficient case

159 Between blood collections in 1996-1999 and 2007, we ascertained

160 ion of B. henselae and suggest that, for cat blood, collection in tubes containing EDTA and subsequen

161 d 2,257 controls (matched on age and date at blood collection) in the Finnish Maternity Cohort, a coh

162 Blood collection is readily available and well accepted,

163 t controlling for physical activity prior to blood collection is routinely incorporated into study de

164 We examined heterogeneity by time since blood collection (</= 3, 4- </= 6, and > 6 years) in str

165 mic score can be obtained within 12 hours of blood collection, making it available for clinical decis

166 Thus, disruptive procedures of blood collection may result in gross overestimates in th

167 was a viable option (8 websites [30%]); (4) blood collection method (ie, through a laboratory or an

168 n products in plasma are stable with routine blood collection methods and reflect oxidation in food,

169 hnicity, smoking, diagnosis year, stage, and blood collection month.

170 al closure (n = 3) or removal of pericardial blood collection (n = 1).

171 among cases diagnosed 5 or more years after blood collection (n = 238) (for highest quintile vs. low

172 tudy without a history of cancer at baseline blood collection (N = 26,711, mean age = 54.6 years [SD

173 located across 10 US states (94% successful blood collections, n = 61/65).

174 nanoparticle system, with an assay time from blood collection of 3.5 hours, may be a promising platfo

175 mong cases diagnosed six or more years after blood collection (OR, 0.60; 95% CI, 0.40-0.90; Ptrend =

176 , smoking, exercise, time between waking and blood collection, or season.

177 Donations in 4 major blood collection organizations were monitored for 15 mon

178 month during July 2020 through May 2021, 17 blood collection organizations with blood donations from

179 more, 1-5 years, and less than 1 year after blood collection (P < 0.05).

180 cluding patients diagnosed within 5 years of blood collection (P for trend = .04); the multivariate H

181 for trend = 0.02) and duration of fasting at blood collection (P for trend = 0.002).

182 To define the optimal blood collection parameters for plasma human immunodefic

183 If replicated in larger cohorts with blood collection prior to any breast development, this s

184 Here, we show that standard blood collection procedures rapidly change the transcrip

185 s" (pools of 16 to 24 donations) by the main blood-collection programs in the United States during th

186 erum collected by venipuncture and capillary blood collection protocols.

187 ge, fasting status, time of day and month of blood collection, race/ethnicity, and timing of blood dr

188 cases diagnosed within 4 years (median) from blood collection (rate ratio = 0.17, 95% confidence inte

189 SARS-CoV-2 antibody assays require invasive blood collection, requiring a remote laboratory and a tr

190 = 323), a median of 6.9 and 15.4 years after blood collection, respectively, were matched to individu

191 Our findings suggest that blood collection services could safely use shorter donat

192 of the BD Vacutainer UltraTouch Push Button Blood Collection Set (UltraTouch; BD Life Sciences, Fran

193 in partly remediating the issue, the role of blood collection set technologies in optimizing blood cu

194 of the BD Vacutainer UltraTouch Push Button Blood Collection Set, which is designed with an ultrathi

195 CC after adjustment for season of and age at blood collection, sex, and country of recruitment (odds

196 a structured medical interview combined with blood collection, skin prick tests, spirometry with bron

197 After controlling for age at blood collection, smoking, parity and duration of breast

198 s were serial bone-marrow biopsy, peripheral blood collections, staging, serial serum and urine parap

199 ases diagnosed longer than 6 years following blood collection (sTNF-R1: OR = 2.1, 95% CI: 1.0-4.0, P(

200 Autologous blood collection techniques, including preoperative auto

201 an vary across samples due to differences in blood collection techniques, such as varying finger pric

202 ta on UVR and other factors near the time of blood collection, the ability to explain 25(OH)D was mod

203 ime; among cases diagnosed >or=8 years after blood collection, the adjusted RR was 3.47 (95% CI, 1.48

204 among those vaccinated > or =15 years before blood collection, the GMT was 58 (95% CI, 44-76) (P = .0

205 However, in men who had fasted (>3 h) at blood collection, the odds ratio for prostate cancer was

206 After blood collection, the protocol takes 2 d, including EV i

207 women less than 50 years old at the time of blood collection, the relative risk was 4.58 (1.75-12.0;

208 g: the potential for in vitro artifacts with blood collection, the technical limitations of clot-base

209 D (n = 380) were identified after the second blood collection through 2016 and were matched to contro

210 (TNF-alpha)-producing T-lymphocytes for all blood collection time points were counted.

211 index, covering time windows from the day of blood collection to 6 years prior.

212 ociations weakened with increasing time from blood collection to case diagnosis and were null for cas

213 ion was unchanged by the length of time from blood collection to case diagnosis.

214 istics (i.e., the procedure taken from whole blood collection to delivery of the samples to analytica

215 age at diagnosis, body mass index, time from blood collection to diagnosis, or calcium intake.

216 Median time from blood collection to patient notification of result was 6

217 Blood collection took place at the beginning and after t

218 Expanding access to simple blood collection tools is essential to monitor, control,

219 a spots (DPS), two filter paper-based remote blood collection tools.

220 uberculosis C(T) values than with the Streck blood collection tube and Streck urine preservative.

221 the trypsin digestion with acid, the type of blood collection tube, different hemolysis levels, diffe

222 patients were used to evaluate the impact of blood collection tube, urine preservative, processing de

223 eased the median pathogen C(T) regardless of blood collection tube.

224 ESAT-6-free IGRA blood collection tubes had acceptable lot-to-lot variabi

225 Use of small-volume blood collection tubes in the ICU may decrease RBC trans

226 ole blood RNA collection, PAXgene and Tempus blood collection tubes, and each comes with their own RN

227 )EDTA tubes than those in Streck and PAXgene blood collection tubes, and they were was significantly

228 The effects of three types of blood collection tubes, two storage temperatures, five p

229 ining (2 plain and 2 self-sealing) capillary blood collection tubes.

230 a technical qualification of antigen-coated blood collection tubes.

231 ects diagnosed <5, 5-10, and >10 years after blood collection versus noncase subjects.

232 s of anesthesia, ureteral urine collections, blood collections, volume replacement, and functional st

233 Median age at blood collection was 63 years.

234 n 24 h or taking a shower/bath within 6 h of blood collection was associated with elevated blood leve

235 Blood collection was completed in the same year.

236 resence of a vaccination scar at the time of blood collection was not determined.

237 Blood collection was performed between 1993 and 1995, an

238 In the ANH group, intraoperative blood collection was performed to a target hemoglobin of

239 In the ANH group, intraoperative blood collection was performed to a target hemoglobin of

240 RNA from peripheral-blood collection was used for DNA microarray analysis.

241 dengue signs and symptoms, chart review, and blood collection, was performed.

242 ort at highest risk of lung cancer for cfDNA blood collection, we could enrich the number of lung can

243 es restricted to pregnancies conceived after blood collection were consistent with the main analyses.

244 Participants diagnosed within 2 years of blood collection were excluded.

245 es, and cardiovascular diseases at or before blood collection were excluded.

246 r increases in TMAO from the first to second blood collection were significantly associated with an i

247 Different routes of blood collection were tested to identify a method to rep

248 ury (mFPI), and behavioral testing, MRI, and blood collections were conducted up to 30 days post-inju

249 spectively enrolled, and repeated peripheral blood collections were performed.

250 Blood collections were used to measure blood glucose, ba

251 d month of and fasting status at the time of blood collection with controls from the same cohort.

252 ts diagnosed >10 years versus <5 years after blood collection, with consistent differential correlati